Published on Monday June 05, 2023

Smooth Drug Development May 2023 News Release

We are working on the following new projects:

  • We signed 2 contracts for bioequivalence trials with Rivaraxoban.
  • We were awarded with a bioequivalence trial with Bedaquiline.

We are happy to reach the following milestones in our projects:

  • We continue enrolling patients in Russia and India into the international phase III clinical trial of the original drug for patients with chronic myeloid leukemia and preparing the CTA submission in Kazakhstan and Pakistan.
  • 320 subjects were randomized into a phase III trial in adhesions during surgeries.
  • 700 subjects were enrolled in the observational program of multivitamins in pregnant and childbearing women. Our clinical team arranged and participated in the Investigators meeting in Kazakhstan.